论文部分内容阅读
为了探讨甲状腺激素时机体β-内啡肽(β-EP)的影响,对42例弥漫性甲亢病人外用血β-EP 测定表明,甲亢治疗前和治疗后好转时,β-EP 较对照组呈非常显著和显著增高,病情恢复使用维持剂量时降至正常.此外,病程在3个月内也有显著升高,超过3个月者无显著变化.分析结果认为,甲亢也是一个应激过程,促肾上腺皮质激素(ACTH)和β-EP 在垂体存在着共同分泌机制,它们与应激和其它刺激呈平行关系,认为这些变化是甲状腺激素自身作用的结果.
In order to investigate the effect of β-EP on thyroid hormones, β-EP of 42 cases of diffuse hyperthyroidism patients showed that β-EP was significantly higher than that of control group before and after treatment of hyperthyroidism Very significantly and significantly increased, the condition was restored to normal when using maintenance dose.In addition, the course of disease also increased significantly within 3 months, no significant change over 3 months.The analysis showed that hyperthyroidism is also a stress process, and promote The adrenocorticotropic hormone (ACTH) and β-EP have a common secretion mechanism in the pituitary. They are in parallel with the stress and other stimuli. These changes are the result of the thyroid hormone’s own actions.